{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T18:45:41Z","timestamp":1781289941760,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.vaccine.2016.07.025","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T17:35:54Z","timestamp":1470332154000},"page":"5414-5419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006\u20132016)"],"prefix":"10.1016","volume":"34","author":[{"given":"Laszlo","family":"Palkonyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.025_b0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","article-title":"A virus obtained from influenza patients","volume":"2","author":"Smith","year":"1933","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.07.025_b0010","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0264-410X(03)00073-2","article-title":"The influenza vaccine licensing process","volume":"21","author":"Wood","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.025_b0015","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.025_b0020","unstructured":"Influenza vaccine viruses and reagents. Geneva: World Health Organization. <http:\/\/www.who.int\/influenza\/vaccines\/virus\/en\/> [accessed 30.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0025","unstructured":"Revised requirements for influenza vaccine (inactivated) and Requirements for influenza vaccine (live). Geneva: World Health Organization; 1979. WHO Technical Report Series No. 638 (Annex 3)."},{"key":"10.1016\/j.vaccine.2016.07.025_b0030","unstructured":"Requirements for influenza vaccine (inactivated) \u2013 revised 1990. Geneva: World Health Organization; 1991. WHO Technical Report Series No. 814 (Annex 2)."},{"key":"10.1016\/j.vaccine.2016.07.025_b0035","unstructured":"Recommendations for the production and control of influenza vaccine (inactivated). Geneva: World Health Organization; 2005. WHO Technical Report Series No. 927 (Annex 3)."},{"key":"10.1016\/j.vaccine.2016.07.025_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/39218","article-title":"A pandemic warning?","volume":"389","author":"De Jong","year":"1997","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.vaccine.2016.07.025_b0045","first-page":"1252","article-title":"Influenza A(H5N1) in Hong Kong: forerunner of a pandemic or just a scientifically interesting phenomenon and a useful exercise in pandemiology?","volume":"142","author":"De Jong","year":"1998","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2016.07.025_b0050","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/338820","article-title":"Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997","volume":"34","author":"Chan","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.025_b0055","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0264-410X(02)00137-8","article-title":"Influenza A(H5N1) in Hong Kong: an overview","volume":"20","author":"Tam","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.025_b0060","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2006.07.021","article-title":"A global pandemic influenza vaccine action plan","volume":"24","author":"Kieny","year":"2006","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.07.025_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","article-title":"Immunogenicity of a monovalent aluminium-adjuvanted influenza whole virus vaccine for pandemic use","volume":"103","author":"Hehme","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.07.025_b0070","unstructured":"WHO monthly risk assessment summary. Influenza at the human-animal interface. Geneva: World Health Organization; 2016. <http:\/\/www.who.int\/influenza\/human_animal_interface\/HAI_Risk_Assessment\/en\/> [accessed 21.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0075","unstructured":"Global pandemic influenza action plan to increase vaccine supply. Geneva: World Health Organization; 2006. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/69388\/1\/WHO_IVB_06.13_eng.pdf> [accessed 21.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0080","unstructured":"Report of the second WHO consultation on the Global Action Plan for Influenza Vaccines (GAP). Geneva: World Health Organization. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/112307\/1\/9789241564410_eng.pdf> [accessed 22.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0085","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2011.02.079","article-title":"WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer","volume":"29S","author":"Friede","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.025_b0090","unstructured":"Global action plan for influenza vaccines. Objective 2. Increase in vaccine production capacity. Geneva: World Health Organization. <http:\/\/www.who.int\/influenza_vaccines_plan\/objectives\/objective2\/en\/>; 2016 [accessed 19.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vaccine.2013.11.066","article-title":"Twenty-five years of the WHO vaccine prequalification programme (1987\u20132012): lessons learned and future perspectives","volume":"33","author":"Dellepiane","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.025_b0100","unstructured":"A system for the prequalification of vaccines for UN supply. Geneva: World Health Organization; 2016. <http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/pq_system\/en\/> [accessed 24.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0105","unstructured":"Global Learning Opportunities for Vaccine Quality. Geneva: World Health Organization. <http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/gtn_index\/en\/> [accessed 26.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0110","unstructured":"Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies. Geneva: World Health Organization; 2013. WHO Technical Report Series, No.978 (Annex 6)."},{"key":"10.1016\/j.vaccine.2016.07.025_b0115","unstructured":"Report of the WHO pandemic influenza A(H1N1) vaccine deployment initiative. Geneva: World Health Organization; 2012. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/44795\/1\/9789241564427_eng.pdf> [accessed 27.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0120","unstructured":"Final pandemic (H1N1) 2009 vaccine deployment update \u2013 10 November 2010. Geneva: World Health Organization. <http:\/\/www.who.int\/csr\/disease\/swineflu\/action\/h1n1_vaccine_deployment_final_update_2010_11_10.pdf> [accessed 20.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0125","unstructured":"Main operational lessons learnt from the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative. Geneva: World Health Organization; 2011. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/44711\/1\/9789241564342_eng.pdf> [accessed 24.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0130","unstructured":"Influenza: PC implementation. Geneva: World Health Organization. <http:\/\/www.who.int\/influenza\/pip\/benefit_sharing\/pc_implementation\/en\/> [accessed 30.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0135","unstructured":"Pandemic influenza preparedness (PIP) framework. Geneva: World Health Organization. <http:\/\/www.who.int\/influenza\/pip\/en\/> [accessed 30.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0140","unstructured":"Global Progress Report 2006\u20132013. Global Action Plan for Influenza Vaccines. Geneva: World Health Organization. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/112307\/1\/9789241507011_eng.pdf?ua=1> [accessed 22.05.16]."},{"key":"10.1016\/j.vaccine.2016.07.025_b0145","unstructured":"Guidelines on regulatory preparedness for human pandemic influenza vaccines (adopted 2007). Geneva: World Health Organization; 2011. WHO Technical Report Series No. 963 (Annex 2)."},{"key":"10.1016\/j.vaccine.2016.07.025_b0150","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2014.05.027","article-title":"Summary of knowledge gaps related to quality and efficacy of current influenza vaccines","volume":"32","author":"Pfleiderer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.025_b0155","unstructured":"WHA Resolution 67.20 Regulatory system strengthening for medical products. Geneva: World Health Organization. <http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA67\/A67_R20-en.pdf> [accessed 29.05.16]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T12:54:22Z","timestamp":1536497662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":31,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0264410X16306089"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006\u20132016)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}